Quralis

QurAlis is a biotechnology company focused on developing precision medicines for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. They leverage advanced technologies to identify and target disease-causing mechanisms at the molecular level. Founded in 2016 by renowned scientists and entrepreneurs, QurAlis has secured significant funding and partnerships to advance its innovative therapeutic programs. Their revenue model primarily involves research and development collaborations, grants, and potential future product sales.

Recent Posts by Quralis

1-3 of 3